Literature DB >> 15944296

Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice.

Stephen T Smiley1, Paula A Lanthier, Kevin N Couper, Frank M Szaba, Jonathan E Boyson, Wangxue Chen, Lawrence L Johnson.   

Abstract

Mice lacking functional CD1d genes were used to study mechanisms of resistance to the protozoan parasite Toxoplasma gondii. Wild-type (WT) BALB/c mice, CD1d-deficient BALB/c mice, and WT C57BL/6 mice all survived an acute oral infection with a low dose of mildly virulent strain ME49 T. gondii cysts. In contrast, most CD1d-deficient C57BL/6 mice died within 2 wk of infection. Despite having parasite burdens that were only slightly higher than WT mice, CD1d-deficient C57BL/6 mice displayed greater weight loss and intestinal pathology. In C57BL/6 mice, CD4(+) cells can cause intestinal pathology during T. gondii infection. Compared with WT mice, infected CD1d-deficient C57BL/6 mice had higher frequencies and numbers of activated (CD44(high)) CD4(+) cells in mesenteric lymph nodes. Depletion of CD4(+) cells from CD1d-deficient mice reduced weight loss and prolonged survival, demonstrating a functional role for CD4(+) cells in their increased susceptibility to T. gondii infection. CD1d-deficient mice are deficient in Valpha14(+) T cells, a major population of NKT cells. Involvement of these cells in resistance to T. gondii was investigated using gene-targeted Jalpha18-deficient C57BL/6 mice, which are deficient in Valpha14(+) T cells. These mice did not succumb to acute infection, but experienced greater weight loss and more deaths than B6 mice during chronic infection, indicating that Valpha14(+) cells contribute to resistance to T. gondii. The data identify CD4(+) cells as a significant component of the marked susceptibility to T. gondii infection observed in CD1d-deficient C57BL/6 mice, and establish T. gondii as a valuable tool for deciphering CD1d-dependent protective mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944296      PMCID: PMC3010175          DOI: 10.4049/jimmunol.174.12.7904

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

1.  Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.

Authors:  A Sher; I P Oswald; S Hieny; R T Gazzinelli
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

2.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

3.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.

Authors:  R Gazzinelli; Y Xu; S Hieny; A Cheever; A Sher
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

4.  Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.

Authors:  F G Araujo
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

5.  Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.

Authors:  J A Langermans; M E van der Hulst; P H Nibbering; R van Furth
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

6.  Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.

Authors:  C A Hunter; C S Subauste; V H Van Cleave; J S Remington
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

7.  SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

8.  Gamma interferon-dependent temporary resistance to acute Toxoplasma gondii infection independent of CD4+ or CD8+ lymphocytes.

Authors:  L L Johnson; F P VanderVegt; E A Havell
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice.

Authors:  I A Khan; K H Ely; L H Kasper
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

10.  Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target.

Authors:  H Arase; N Arase; Y Kobayashi; Y Nishimura; S Yonehara; K Onoé
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  17 in total

Review 1.  V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes.

Authors:  Yuki Kinjo; Mitchell Kronenberg
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

2.  Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.

Authors:  Eiichiro Kawai; Fumitaka Sato; Seiichi Omura; Nicholas E Martinez; Pratap C Reddy; Masaru Taniguchi; Ikuo Tsunoda
Journal:  J Neuroimmunol       Date:  2014-11-08       Impact factor: 3.478

3.  In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis.

Authors:  I K Mullarky; F M Szaba; C G Winchel; M A Parent; L W Kummer; N Mackman; L L Johnson; S T Smiley
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

Review 4.  Interleukin 23 in Crohn's disease.

Authors:  Ahmet Eken; Akhilesh K Singh; Mohamed Oukka
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

5.  Cross-regulation of T regulatory-cell response after coxsackievirus B3 infection by NKT and γδ T cells in the mouse.

Authors:  Wei Liu; Mohamad Moussawi; Brian Roberts; Jonathan E Boyson; Sally A Huber
Journal:  Am J Pathol       Date:  2013-06-05       Impact factor: 4.307

6.  Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.

Authors:  Diego Sánchez-Martínez; Matteo L Baroni; Francisco Gutierrez-Agüera; Heleia Roca-Ho; Oscar Blanch-Lombarte; Sara González-García; Montserrat Torrebadell; Jordi Junca; Manuel Ramírez-Orellana; Talía Velasco-Hernández; Clara Bueno; José Luís Fuster; Julia G Prado; Julien Calvo; Benjamin Uzan; Jan Cools; Mireia Camos; Françoise Pflumio; María Luisa Toribio; Pablo Menéndez
Journal:  Blood       Date:  2019-02-22       Impact factor: 22.113

7.  Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.

Authors:  Thierry Mallevaey; Josette Fontaine; Laetitia Breuilh; Christophe Paget; Alexandre Castro-Keller; Catherine Vendeville; Monique Capron; Maria Leite-de-Moraes; François Trottein; Christelle Faveeuw
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

8.  Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection.

Authors:  Michelle A Parent; Lindsey B Wilhelm; Lawrence W Kummer; Frank M Szaba; Isis K Mullarky; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

9.  Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection.

Authors:  Kevin N Couper; Paula A Lanthier; Georgia Perona-Wright; Lawrence W Kummer; Wangxue Chen; Stephen T Smiley; Markus Mohrs; Lawrence L Johnson
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

10.  Influence of indigenous microbiota on experimental toxoplasmosis in conventional and germ-free mice.

Authors:  Bruna B Nascimento; Christiane T Cartelle; Maria de L Noviello; Breno V Pinheiro; Ricardo W de Almeida Vitor; Danielle da G Souza; Simone de Vasconcelos Generoso; Valbert N Cardoso; Flaviano Dos S Martins; Jacques R Nicoli; Rosa M E Arantes
Journal:  Int J Exp Pathol       Date:  2017-09-11       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.